MOVICOL Sachets of powder for oral use, 50 pcs

Powder to manufacture a solution to take

Active ingredients:
13.8 g Movicol® for the production of a solution contains the following components:
- Macrogol 3350 13.125 g
- Sodium chloride 0.3507 g
- Sodium hydrogen carbonate 0.1785 g
- Potassium chloride 0.0466 g

13.8 g Movicol® for the production of a solution also contains the other

Ingredients:
Lemon/limon aroma and acesulfam potassium as a sweetener. Lemon/limon aroma contains the following components: Arabic rubber, maltodextrin, lime oil, lemon oil, citral, citric acid and water.

Application areas:
To treat acute and chronic constipation in adults, older patients and adolescents aged 12 and over.

The predictable solution for constipation problems - Movicol®

Constipation is a topic that affects everyday life and well -being of many people.
About every third adult suffers occasionally or even chronically from constipation. The frequency generally increases with age. Women are affected by twice as often as men. Triggers can e.g. low -fiber nutrition, lack of exercise, medication or their side effects as well as neurological, endocrine and systemic diseases1.

Do you suffer from constipation problems? Then the Movicol® the predictable solution is for you.

Movicol® with its active ingredient macrogol quickly helps to do a comfortable intestinal activity. The difference to other known laxatives lies in its physiological principle of action, which is based on the natural processes of the organism. Constipation problems are reliably but gently solved. Due to the easily controllable effect, Movicol® is ideal in the usual daily routine. Already the regular intake of 1-3 bags per day usually enables a soft chair.

The gentle and discrete effect without additional stress on the organism allows dissipation in the usual environment - e.g. at home. Excess diarrhea after taking Movicol® ready for drinking with suddenly uncontrollable stool urge. There is also no risk of getting used to or an increase in dose even after long -term intake.

1021/019- S2K- guideline Chronic constipation, current status 02/2013; http: // www. awmf.org/uploads/tx_szleitlinien/021-019l_s2k_chronische_obstipation_2013-01.pdf on July 6th, 2017 at 10:30 am